Orthofix Medical Inc
OFIX15.480USD
+0.540+3.61%
Cierre 09/18, 16:00（ET）Cotizaciones retrasadas 15 min
611.20MCap. mercado
PérdidaP/E TTM
Más Datos de Orthofix Medical Inc Compañía
Orthofix Medical Inc. is a global medical technology company. Its Global Spine segment offers two product categories: Bone Growth Therapies and Spinal Implants, Biologics, and Enabling Technologies. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures. This segment specializes in the design, development, and marketing of external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. Spinal Implants, Biologics, and Enabling Technologies includes a portfolio of spine fixation and motion preservation implant products used in surgical procedures of the spine.
Información de la empresa
Símbolo de cotizaciónOFIX
Nombre de la empresaOrthofix Medical Inc
Fecha de salida a bolsaApr 24, 1992
Director ejecutivoMr. Massimo Calafiore
Número de empleados1616
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 24
Dirección3451 Plano Pkwy
CiudadLEWISVILLE
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal75056-9453
Teléfono12149372000
Sitio Webhttps://ir.orthofix.com/ir-home/default.aspx
Símbolo de cotizaciónOFIX
Fecha de salida a bolsaApr 24, 1992
Director ejecutivoMr. Massimo Calafiore
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jason M. Hannon
Mr. Jason M. Hannon
Independent Director
Independent Director
69.64K
+37.09%
Mr. Michael M. Finegan
Mr. Michael M. Finegan
Independent Chairman of the Board
Independent Chairman of the Board
55.80K
+87.78%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
54.07K
+53.48%
Mr. Charles R. (Chuck) Kummeth
Mr. Charles R. (Chuck) Kummeth
Independent Director
Independent Director
43.29K
+77.08%
Mr. Massimo Calafiore
Mr. Massimo Calafiore
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
40.09K
+33.23%
Mr. Patrick G. Fisher
Mr. Patrick G. Fisher
President - Global Orthopedics
President - Global Orthopedics
28.05K
-6.64%
Mr. Max Reinhardt
Mr. Max Reinhardt
President - Global Spine
President - Global Spine
3.16K
-34.23%
Ms. Julie B. Andrews
Ms. Julie B. Andrews
Chief Financial Officer
Chief Financial Officer
--
--
Mr. John Bell (Jack) Henneman, III
Mr. John Bell (Jack) Henneman, III
Independent Director
Independent Director
--
--
Mr. Wayne C. Burris
Mr. Wayne C. Burris
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jason M. Hannon
Mr. Jason M. Hannon
Independent Director
Independent Director
69.64K
+37.09%
Mr. Michael M. Finegan
Mr. Michael M. Finegan
Independent Chairman of the Board
Independent Chairman of the Board
55.80K
+87.78%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
54.07K
+53.48%
Mr. Charles R. (Chuck) Kummeth
Mr. Charles R. (Chuck) Kummeth
Independent Director
Independent Director
43.29K
+77.08%
Mr. Massimo Calafiore
Mr. Massimo Calafiore
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
40.09K
+33.23%
Mr. Patrick G. Fisher
Mr. Patrick G. Fisher
President - Global Orthopedics
President - Global Orthopedics
28.05K
-6.64%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Spinal Implants
108.79M
56.18%
Bone Growth Therapies
55.05M
28.43%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
161.68M
83.49%
International
31.96M
16.51%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Spinal Implants
108.79M
56.18%
Bone Growth Therapies
55.05M
28.43%
Estadísticas de accionistas
Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Engine Capital Management, LP
10.77%
Rubric Capital Management LP
9.42%
Paradigm Capital Management, Inc.
8.46%
Armistice Capital LLC
7.54%
BlackRock Institutional Trust Company, N.A.
7.26%
Otro
56.56%
Accionistas
Accionistas
Proporción
Engine Capital Management, LP
10.77%
Rubric Capital Management LP
9.42%
Paradigm Capital Management, Inc.
8.46%
Armistice Capital LLC
7.54%
BlackRock Institutional Trust Company, N.A.
7.26%
Otro
56.56%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
41.97%
Hedge Fund
24.84%
Investment Advisor
21.10%
Research Firm
3.06%
Individual Investor
2.44%
Pension Fund
0.53%
Bank and Trust
0.32%
Insurance Company
0.04%
Otro
5.70%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
383
34.24M
86.73%
-7.53M
2025Q1
400
36.08M
92.22%
-6.00M
2024Q4
406
35.79M
91.88%
-7.42M
2024Q3
405
37.21M
98.94%
-7.35M
2024Q2
405
38.09M
101.30%
-7.13M
2024Q1
403
37.91M
101.53%
-6.95M
2023Q4
403
37.82M
103.01%
-4.07M
2023Q3
385
35.80M
97.80%
-3.46M
2023Q2
374
34.87M
95.30%
-3.10M
2023Q1
386
34.87M
101.51%
+7.31M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Engine Capital Management, LP
4.25M
10.85%
+510.28K
+13.64%
May 07, 2025
Rubric Capital Management LP
3.69M
9.43%
--
--
Mar 31, 2025
Paradigm Capital Management, Inc.
2.48M
6.33%
-4.20K
-0.17%
Mar 31, 2025
Armistice Capital LLC
2.96M
7.56%
-36.00K
-1.20%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.76M
7.04%
+3.76K
+0.14%
Mar 31, 2025
Juniper Investment Company, LLC
2.39M
6.09%
+249.13K
+11.66%
Apr 09, 2025
The Vanguard Group, Inc.
2.17M
5.54%
+54.53K
+2.58%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
812.27K
2.07%
+152.79K
+23.17%
Mar 31, 2025
State Street Global Advisors (US)
860.34K
2.2%
-24.51K
-2.77%
Mar 31, 2025
AYAL Capital Advisors Limited
539.77K
1.38%
-101.00
-0.02%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de sep
Actualizado: sáb., 6 de sep
Nombre
Proporción
Innovator US Small Cap Managed Floor ETF
0%
Dimensional US Core Equity 1 ETF
0%
VictoryShares Small Cap Free Cash Flow ETF
0%
DFA Dimensional US Small Cap Value ETF
0%
iShares Core S&P Small-Cap ETF
0%
SPDR S&P SmallCap 600 ESG ETF
0%
SPDR Portfolio S&P 1500 Composite Stock Market ETF
0%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
0%
SPDR S&P 600 Small Cap Value ETF
0%
iShares ESG Select Screened S&P Small-Cap ETF
0%
Ver más
Innovator US Small Cap Managed Floor ETF
Proporción0%
Dimensional US Core Equity 1 ETF
Proporción0%
VictoryShares Small Cap Free Cash Flow ETF
Proporción0%
DFA Dimensional US Small Cap Value ETF
Proporción0%
iShares Core S&P Small-Cap ETF
Proporción0%
SPDR S&P SmallCap 600 ESG ETF
Proporción0%
SPDR Portfolio S&P 1500 Composite Stock Market ETF
Proporción0%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
Proporción0%
SPDR S&P 600 Small Cap Value ETF
Proporción0%
iShares ESG Select Screened S&P Small-Cap ETF
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
